Showing results (261-270 of 282) with videos related to

Sort By:
Pageof 29
Anti-Cancer Drug Design|February 25, 1998
Antiproliferative activity of colchicine analogues on MDR-positive and MDR-negative human cancer cell linesR De Vincenzo, G Scambia, C Ferlini, et al.
British Journal of Haematology|January 1, 1997
Purified unfractionated G-CSF/chemotherapy mobilized CD34+ peripheral blood progenitors and not bone marrow CD34+ progenitors undergo selective erythroid differentiation in liquid culture in the presence of erythropoietin and stem cell factorL Pierelli, G Scambia, G Menichella, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|April 25, 2020
Outcome of twin-twin transfusion syndrome according to Quintero stage of disease: systematic review and meta-analysisD Di Mascio, A Khalil, A D'Amico, et al.
Molecular and Cellular Endocrinology|February 1, 1992
Effects of dexamethasone on the growth and epidermal growth factor receptor expression of the OVCA 433 ovarian cancer cellsG Ferrandina, G Scambia, P Benedetti Panici, et al.
Cancer Treatment Reviews|November 13, 2015
Tyrosine-kinases inhibitors in recurrent platinum-resistant ovarian cancer patientsC Marchetti, I Palaia, F De Felice, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 1, 1993
Expression of HER-2/neu oncoprotein, DNA-ploidy and S-phase fraction in advanced ovarian cancerG. Scambia, P. Benedetti Panici, G. Ferrandina, et al.
Minerva Ginecologica|February 11, 2009
[The role of laparoscopy in ovarian carcinoma]R Angioli, L Muzii, C Battista, et al.
Journal of Chemotherapy (Florence, Italy)|May 9, 2009
Outpatient parenteral antibiotic therapy in the elderly: an Italian observational multicenter studyS Esposito, S Leone, S Noviello, et al.
Current Molecular Medicine|September 1, 2012
Past, present and future strategies of immunotherapy in gynecological malignanciesF Bellati, C Napoletano, I Ruscito, et al.
British Journal of Cancer|January 1, 1997
High-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: non-haematological, haematological toxicities and role of growth factor administrationP Benedetti Panici, L Pierelli, G Scambia, et al.
Pageof 29